RESMED, Inc. (NY:RMD)
50.25
0.42 (0.83%)
| RESMED, Inc. (NY:RMD) Delayed : |
| Previous Close |
$50.67 |
|
52 Week High |
$51.64 |
|
| Open |
$50.56 |
|
52 Week Low |
$30.53 |
| Day High |
$50.58 |
|
P/E |
24.04 |
| Day Low |
$49.81 |
|
EPS |
$2.09 |
| Volume |
609,465 |
|
|
|
| More RMD Info:
Chart
SEC Filings
Profile
Historical
Options
|
ResMed Summary
ResMed, Inc. engages in the design, manufacture, and marketing of
equipment for the diagnosis and treatment of -disordered breathing,
including obstructive sleep apnea, and other respiratory disorders that
occur during sleep. It offers airflow generators, diagnostic products,
mask systems, headgear, and other accessories, including humidifiers,
cold passover humidifiers, carry bags, and breathing ...more
Executives
Peter Farrell - Chairman
Kieran Gallahue - CEO
Links
http://www.resmed.com/
-
Nov 6, 2009 11:00 AM
Notable Analyst Rating Changes 11/06: GE, CBS, HD/LOW, M Upgrade; ESLR, RMD, SUN Downgrade
-
Nov 6, 2009 10:19 AM
Morgan Stanley Downgrades ResMed (RMD) to Equalweight
-
Nov 6, 2009 08:34 AM
Jefferies & Co Downgrades ResMed (RMD) to Hold
-
Nov 5, 2009 05:15 PM
ResMed (RMD) Tops Q3 Views
-
Nov 4, 2009 02:42 PM
Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
View All Reports
StreetInsider Reports on RMD by Category
-
Oct 31, 2009 01:15 PM
World Series trade #2: ResMed (RMD)
-
Oct 31, 2009 09:20 AM
Six World Series trades
-
Oct 15, 2009 03:32 AM
Methodology: Here's How I Pick Stocks
-
Oct 5, 2009 12:05 PM
Analyst upgrades, downgrades and initiations: AMD, GD, COP, MT, TIVO, WFC ...
-
Sep 10, 2009 03:06 AM
Ken Griffin's Citadel Fund: Options Eye Candy
View All Blogs
Comments on recent RMD articles
Comments on RMD
No comments are currently available.
on Jul 2, 2008
at 02:16 AM Resmed insiders Well after talking to relatives that work for the comany in Poway. It sounds as though some restuctureing is going on in upper and middle management. Segments of the Biz are being moved and seperated from the Poway location and auditors seem to be comming through a little more often than usual. No solid evidence of a buyout is seen but people at the comany are getting skiddish.
Article: ResMed (RMD) Climbs on Respironics (RESP) Buyout